King Gary A. 4
4 · MYRIAD GENETICS INC · Filed Aug 2, 2019
Insider Transaction Report
Form 4
King Gary A.
Exec. VP International Ops
Transactions
- Exercise/Conversion
Common Stock
2019-08-01$23.98/sh+10,000$239,800→ 144,871 total - Exercise/Conversion
Common Stock
2019-08-01$19.47/sh+20,000$389,400→ 154,871 total - Sale
Common Stock
2019-08-01$43.48/sh−10,000$434,816→ 134,871 total - Exercise/Conversion
Common Stock
2019-08-01$26.49/sh+30,000$794,700→ 164,871 total - Sale
Common Stock
2019-08-01$39.44/sh−20,000$788,810→ 134,871 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2019-08-01−20,000→ 7,432 totalExercise: $19.47Exp: 2021-09-13→ Common Stock (20,000 underlying) - Sale
Common Stock
2019-08-01$46.19/sh−30,000$1,385,703→ 134,871 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2019-08-01−30,000→ 106,225 totalExercise: $26.49Exp: 2021-09-17→ Common Stock (30,000 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2019-08-01−10,000→ 1,830 totalExercise: $23.98Exp: 2022-03-07→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.